We had a recent pump and dump on the back of BIT surging.  The...

We had a recent pump and dump on the back of BIT surging.  The company seems undervalued where it is now with a market cap of 10 million and an almost commercialised product.  I don't think there is much doubt that the Felix works, they are just getting confirmation from industry.  It's not like a drug undergoing clinical trials to see if it actually works, it's more like a working product being sent out for industry to try out and see if they like it.  What would be really valuable is knowing how much cash they've got left - does anyone have a guesstimate?